Long-term effects of nitrendipine on hemodynamics and oxygen transport in patients with cor pulmonale.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Chest

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/CHEST.89.1.141PMID 2934230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.

  2015cited by this paper
• Independence of oxygen consumption and systemic oxygen transport in patients with either stable pulmonary hypertension or refractory left ventricular failure.

  2015cited by this paper
• The Dependence of Oxygen Uptake on Oxygen Delivery in the Adult Respiratory Distress Syndrome1–4

  2015cited by this paper
• Relationship Between Oxygen Uptake and Oxygen Transport in Stable Patients with Chronic Obstructive Pulmonary Disease: Physiologic Effects of Nitroprusside and Hydralazine

  1985cited by this paper
• Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease.

  1984cited by this paper
• Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study.

  1984cited by this paper
• Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension.

  1984cited by this paper
• Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.

  1983cited by this paper
• The Slow‐Channel Calcium Blocking Agent, Nitrendipine, and Coronary Collateral Blood Flow

  1983cited by this paper
• Effects of oral hydralazine on gas exchange in patients with cor pulmonale.

  1983cited by this paper
• Deleterious effects of hydralazine in patients with pulmonary hypertension.

  1982cited by this paper
• Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.

  1982cited by this paper
• Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.

  1981cited by this paper
• Hemodynamics at rest and during exercise after oral hydralazine in patients with cor pulmonale.

  1981cited by this paper
• Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.

  1981cited by this paper
• Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.

  1981cited by this paper
• Calcium antagonists in exercise-induced asthma.

  1981cited by this paper
• A calcium antagonist, nifedipine, modifies exercise-induced asthma.

  1981cited by this paper
• Prognosis of pulmonary hypertension in chronic obstructive pulmonary disease.

  1980cited by this paper
• The dependence of oxygen uptake on oxygen delivery in the adult respiratory distress syndrome.

  1980cited by this paper
• Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study.

  1979cited by this paper
• Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease.

  1979cited by this paper
• Patterns of cardiovascular dysfunction in chronic obstructive lung disease.

  1972cited by this paper

• Right Ventricular Dysfunction in Chronic Obstructive

  2017cites this paper
• The Shortened Unnatural Life History of Primary Pulmonary Hypertension

  2015cites this paper
• Pulmonary Hypertension in Chronic Lung Diseases and/or Hypoxia

  2013cites this paper
• Paracrine proliferative signaling by senescent cells in world health organization group 3 pulmonary hypertension: age corrupting youth?

  2011cites this paper
• Normalization of deranged signal transduction in lymphocytes of COPD patients by the novel calcium channel blocker H-DHPM.

  2011cites this paper
• Pulmonary arterial hypertension and lung transplantation.

  2010cites this paper
• Pulmonary Arterial Hypertension and Lung Transplantation

  2010cites this paper
• Pulmonary Hypertension in COPD: A Review and Consideration of the Role of Arterial Vasodilators

  2009cites this paper
• The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease

  2002cites this paper
• Chapter 19 – Pulmonary Vessels

  2002cites this paper
• Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.

  2000cites this paper
• The effect of isradipine on pulmonary arterial pressure in patients with chronic obstructive pulmonary disease and cor pulmonale

  2000cites this paper
• A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD.

  1997cites this paper
• Calciumantagonisten bei pulmonaler Hypertonie

  1996cites this paper
• Pulmonary Circulation, Cardiac Function and Fluid Balance

  1995cites this paper
• Regulation of pulmonary vascular tone.

  1995cites this paper
• Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two.

  1994cites this paper
• Effects of Single Intravenous Administration of Urapidil and Diltiazem in Patients with Nonfixed Pulmonary Hypertension Secondary to Chronic Obstructive Lung Disease

  1994cites this paper
• Investigation and management of pulmonary hypertension in chronic obstructive pulmonary disease.

  1993cites this paper
• Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease.

  1993cites this paper
• The effects of flosequinan on hemodynamics and oxygen delivery in cor pulmonale.

  1992cites this paper
• The effect of the calcium antagonist, isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double‐blind, placebo‐controlled study

  1991cites this paper
• Pharmacologic Treatment of Primary and Secondary Pulmonary Hypertension

  1991cites this paper
• Right ventricular dysfunction in chronic obstructive pulmonary disease. Evaluation and management.

  1991cites this paper
• Cor pulmonale in chronic obstructive pulmonary disease. Circulatory pathophysiology and management.

  1990cites this paper
• Comparison of pulmonary and systemic effects of adenosine triphosphate in chronic obstructive pulmonary disease--ATP: a pulmonary controlled vasoregulator?

  1990cites this paper
• [The effect of calcium antagonists on pulmonary hemodynamics in patients with chronic bronchitis with manifest and latent pulmonary hypertension].

  1989cites this paper
• Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD.

  1989cites this paper
• Nifedipine in chronic cor pulmonale: acute and relatively long‐term effects

  1988cites this paper
• [Principles of the treatment of chronic bronchitis].

  1988cites this paper
• Can pulmonary vasodilators improve survival in cor pulmonale due to hypoxic chronic bronchitis and emphysema?

  1988cites this paper
• Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

  1987cites this paper
• The kingdom of the near-dead. The shortened unnatural life history of primary pulmonary hypertension.

  1987cites this paper
• Cardiopulmonary Interactions in Acute Respiratory Failure

  1987cites this paper
• Pharmacological interventions in acute respiratory failure

  1987cites this paper
• Therapeutic Applications to Pulmonary Circulation in Chronic Obstructive Lung Disease

  1986cites this paper
• Pulmonary hypertension, right ventricular failure, and vasodilator therapy. Making pathophysiologic sense.

  1986cites this paper
• Pulmonary Hypertension , Right Ventricular Failure , and Vasodilator Therapy Making Pathophyslologic Sense

  year unknowncites this paper